Business ❯Pharmaceuticals

Clinical Trials

Experimental Drug Early Stage Trials Blarcamesine Drug Approval Drug Development

Wegovy Approved for Heart Health, Faces Insurance Coverage Challenges

The FDA's expanded approval of Wegovy for cardiovascular benefits in obese adults doesn't guarantee broader insurance coverage due to cost concerns.

Class Action Lawsuit Filed Against Anavex Life Sciences Corp.

Viking Therapeutics' Stock Soars on Promising Weight-Loss Drug Results